{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-25-004746","form_type":"8-K","ticker":"TLRY","cik":"0001731348","company_name":"Tilray Brands, Inc.","filed_at":"2025-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.829579+00:00","generated_at":"2026-05-18T00:20:11.519306+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tilray Q4/FY2025: net loss $1.27B on $2.1B impairment; guides FY2026 EBITDA $62-72M","bullets":["FY2025 net revenue $821.3M (+4% YoY); Q4 net revenue $224.5M (down 2% from $229.9M).","Q4 net loss $1.27B includes $1.4B non-cash goodwill impairment; adjusted net income $20.2M.","Cannabis gross margin improved to 44% in Q4 (vs 40%); international cannabis revenue up 71% Q4.","Debt reduced ~$100M; cash+marketable securities $256M; net debt/EBITDA 0.3x.","FY2026 adjusted EBITDA guidance $62M-$72M (13-31% growth vs FY2025 $55.0M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-25-004746","json":"https://secwatch.observer/filing/0001171843-25-004746.json","markdown":"https://secwatch.observer/filing/0001171843-25-004746.md","text":"https://secwatch.observer/filing/0001171843-25-004746.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1731348/000117184325004746/0001171843-25-004746-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1731348/000117184325004746/f8k_072825.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:20:11.519306+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}